Full Breakdown
Controversy Surrounds Anti-Trans Resolution in New York Medical Community
3/27/2026, 2:16:21 AM
Core Event: Proposed Resolution on Gender-Affirming Care
A contentious resolution regarding gender-affirming surgery for minors is set to be debated by the Medical Society of the State of New York (MSSNY) this weekend. The resolution, introduced by Dr. Scot Glasberg, a Manhattan-based surgeon, seeks to endorse a controversial position statement from the American Society of Plastic Surgeons (ASPS) that recommends delaying gender-related surgeries until patients are at least 19 years old. This statement has been criticized for promoting anti-trans rhetoric and misinformation.
Background & Context: The ASPS Position Statement
In February 2023, the ASPS issued a position statement that was not officially recognized as a clinical practice guideline but nonetheless influenced medical practices across the country. The statement has been linked to political agendas, particularly referencing an executive order from former President Donald Trump that similarly set the age limit for gender-affirming surgeries. The ASPS's stance has led to an increase in hospitals and clinics denying surgeries to transgender youth and adults.
Key Figures: Dr. Scot Glasberg and Opposition Voices
Dr. Scot Glasberg is at the center of this controversy, having played a significant role in the ASPS's position statement. Critics, including Alex Sheldon, executive director of GLMA, argue that Glasberg's resolution perpetuates harmful narratives about gender-affirming care. Sheldon stated, “Dr. Glasberg is essentially attempting to widen the harm caused by what the ASPS was able to put out in a position statement.”
Official Statements & Responses
Dr. Thomas Lee, Executive Vice President of MSSNY, clarified that even if Glasberg's resolution passes, it would not create binding medical practice rules. He emphasized, “We have no binding power. We are not law enforcement.” This sentiment reflects the ongoing debate within the medical community regarding the implications of such resolutions.
Criticism & Opposition: Concerns Over Misinformation
Critics of Glasberg's resolution have highlighted several misleading claims made within it, particularly regarding the quality of evidence supporting gender-affirming care. They argue that the assertion of low-quality evidence is unfounded and that mental health evaluations are already a critical component of the care process. Additionally, another proposal at the MSSNY conference, led by Dr. Arthur Fougner, has been criticized for framing puberty blockers as "experimental," further complicating the discourse around transgender healthcare.
Conflicting Reports & Gaps: Media Coverage and Misinterpretations
The American Medical Association (AMA) has requested corrections from the New York Times regarding its characterization of the AMA's stance on gender-related surgical treatments for minors. The AMA clarified that it did not endorse the ASPS statement, highlighting the discrepancies in media reporting that can influence public perception and policy.
What's Next: Upcoming MSSNY Vote
The MSSNY House of Delegates will convene in Rochester, New York, to deliberate on Glasberg's resolution and other proposals related to gender-affirming care. The outcome of this vote could significantly impact the future of transgender healthcare in New York, as advocates and opponents alike prepare to voice their opinions on this critical issue.
